RVMD (Revolution Medicines) Ending Cash Position: $820.29 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

RVMD Revolution Medicines Inc RVMD
25 GF Score
Price $202.00
! 3 Warning Signs
View Full Analysis

What is Revolution Medicines Ending Cash Position?

Revolution Medicines RVMD -1.59% 25 Ending Cash Position is $820.29 Mil as of Jun. 2026. GuruFocus rates RVMD with a GF Score™ of 25/100. The stock has 3 warning signs investors should review.

Revolution Medicines's Ending Cash Position for the quarter that ended in Jun. 2026 was $820.29 Mil.

Revolution Medicines's quarterly Ending Cash Position increased from Dec. 2025 ($388.60 Mil) to Mar. 2026 ($445.80 Mil) and increased from Mar. 2026 ($445.80 Mil) to Jun. 2026 ($820.29 Mil).

Revolution Medicines's annual Ending Cash Position declined from Dec. 2023 ($699.18 Mil) to Dec. 2024 ($546.76 Mil) and declined from Dec. 2024 ($546.76 Mil) to Dec. 2025 ($388.60 Mil).

Revolution Medicines Ending Cash Position Related Terms

Revolution Medicines Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Revolution Medicines's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Revolution Medicines Ending Cash Position Chart

Revolution Medicines Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only 110.23 163.15 699.18 546.76 388.60

Revolution Medicines Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 406.35 222.30 388.60 445.80 820.29
RVMD
25GF Score
Revolution Medicines Inc RVMD
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Revolution Medicines Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Revolution Medicines's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=546.762+-158.159
=388.60

Revolution Medicines's Ending Cash Position for the quarter that ended in Jun. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=388.603+431.69
=820.29

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of $820.29 Mil mean?
Revolution Medicines (RVMD) has a Ending Cash Position of $820.29 Mil as of Jun. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Revolution Medicines and its competitors.
Is Revolution Medicines' Ending Cash Position too high?
Revolution Medicines' current Ending Cash Position is $820.29 Mil. Overall, Revolution Medicines has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Revolution Medicines' Ending Cash Position compare to ALNY and ONC?
Revolution Medicines' Ending Cash Position of $820.29 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Biotechnology company?
A good Ending Cash Position depends on the Biotechnology industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Revolution Medicines and its competitors. Revolution Medicines's current Ending Cash Position is $820.29 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Revolution Medicines stock overvalued right now?
Revolution Medicines (RVMD) has a current Ending Cash Position of $820.29 Mil. The current Ending Cash Position is $820.29 Mil. Revolution Medicines' overall GF Score™ is 25/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Revolution Medicines (RVMD), the current Ending Cash Position is $820.29 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Revolution Medicines Business Description

Other Exchanges 1RVMD:Italy42Z:Germany
Address 700 Saginaw Drive, Redwood City, CA, USA, 94063
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.
25GF Score

Get the complete analysis for RVMD

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$202.00
Price